The NF-κB pathway is chronically activated in NASH and its activation in obese individuals is often associated with higher circulating levels of pro-inflammatory cytokines such as TNF, IL-6, and IL-1β [13,14]. The gene discussed is NFKB1; the disease is metabolic dysfunction-associated steatohepatitis.